The objectives of the proposed research are to determine how Ca2+/calmodulin-dependent protein kinase IV (CaMK IV) participates in Ca2+/calmodulin regulated signal transduction cascades and whether this enzyme influences development of the cells in which it is expressed. The proposed experiments will utilize transgenic mice and mice in which the CaMK IV gene has been disrupted by gene targeting.
Aim 1 will assess defects in transgenic mice expressing an inactive form of CaMK IV specifically in T-cells.
In Aim 2, the role of CaMK IV and its activating kinase in receptor-mediated signaling in T-cells will be examined to determine if CaMK IV is required to promote cell proliferation or to prevent cell apoptosis in response to mitogenic stimuli.
In Aim 3, the consequences of disruption of the CaMK IV gene on the development of the tissues in which it is expressed will be investigated.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
5R01HD007503-26
Application #
2883114
Study Section
Biochemical Endocrinology Study Section (BCE)
Program Officer
Rankin, Tracy L
Project Start
1977-05-01
Project End
2001-02-28
Budget Start
1999-03-01
Budget End
2000-02-29
Support Year
26
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Duke University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
071723621
City
Durham
State
NC
Country
United States
Zip Code
27705
Schneider, Judsen; Skelton, Rachel L; Von Stetina, Stephen E et al. (2012) UNC-4 antagonizes Wnt signaling to regulate synaptic choice in the C. elegans motor circuit. Development 139:2234-45
Schwartz, N B (1995) The 1994 Stevenson Award Lecture. Follicle-stimulating hormone and luteinizing hormone: a tale of two gonadotropins. Can J Physiol Pharmacol 73:675-84